We randomly assigned 863 infants ( gestational age , 23 weeks 0 days to 27 weeks 6 days ) to early ( within 24 hours after birth ) inhaled budesonide or placebo until they no longer required oxygen and positive-pressure support or until they reached a postmenstrual age of 32 weeks 0 days .